Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced interim results from a Phase 1/2a clinical study of ARO-CFB, the company’s investigational RNA interference (RNAi) therapeutic targeting ...

In a report released today, Brendan Smith from TD Cowen maintained a Hold rating on Recursion Pharmaceuticals (RXRX – Research Report). The ...

Arrowhead (ARWR) announced interim results from a Phase 1/2a clinical study of ARO-CFB, the company’s investigational RNA interference, or ...

PAR Technology , a global foodservice technology company, today announces that Condado Tacos, the rapidly growing restaurant brand celebrated for its custom tacos and bold flavors, has selected PAR® ...

Endocrinology, Chairman of the Board of Directors of Anasens, a company with innovative technology enabling the rapid quantification of biomarkers in any environment requiring immediate response, ...

Arrowhead Pharmaceuticals Inc is a biotechnology company. It is engaged in the development of medicine to treat diseases such as hepatitis B, and thrombosis with a genetic origin, primarily divided by ...

Biopharmaceutical company developing drugs for neurological disorders.

U.S. Marketscategory Wall St indexes fall with inflation data and rates in focus December 10, 2024 U.S. Marketscategory Wall Street closes down as tech stocks fall December 9, 2024 U.S ...

New Delhi [India], December 8 (ANI): Prime Minister Narendra Modi expressed his pride after Archbishop George Jacob Koovakad from Kerala ...